Authors
Loading...
Experiments show SRSF2 mutations enhance venetoclax and MCL1 sensitivity in AML, indicating altered apoptosis regulation due to splicing changes.
Matsushima et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: